Hsc70 promotes anti-tumor immunity by targeting PD-L1 for lysosomal degradation
Hsc70 promotes anti-tumor immunity by targeting PD-L1 for lysosomal degradation is a paper indexed in PICO Portal from OpenAlex.
How many citations does Hsc70 promotes anti-tumor immunity by targeting PD-L1 for lysosomal degradation have?
Hsc70 promotes anti-tumor immunity by targeting PD-L1 for lysosomal degradation has 49 citations in the OpenAlex counts PICO Portal stores.
When was Hsc70 promotes anti-tumor immunity by targeting PD-L1 for lysosomal degradation published?
Hsc70 promotes anti-tumor immunity by targeting PD-L1 for lysosomal degradation has 2024 year in the PICO Portal index.
What is the open-access status of Hsc70 promotes anti-tumor immunity by targeting PD-L1 for lysosomal degradation?
Hsc70 promotes anti-tumor immunity by targeting PD-L1 for lysosomal degradation has gold oa status in the PICO Portal index.
What is the DOI of Hsc70 promotes anti-tumor immunity by targeting PD-L1 for lysosomal degradation?
The DOI for Hsc70 promotes anti-tumor immunity by targeting PD-L1 for lysosomal degradation is on the source record.
What is the PMID of Hsc70 promotes anti-tumor immunity by targeting PD-L1 for lysosomal degradation?
The PMID for Hsc70 promotes anti-tumor immunity by targeting PD-L1 for lysosomal degradation is on the source record.
What is the OpenAlex record for Hsc70 promotes anti-tumor immunity by targeting PD-L1 for lysosomal degradation?
The OpenAlex for Hsc70 promotes anti-tumor immunity by targeting PD-L1 for lysosomal degradation is on the source record.